Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter sent	Tue, 11/08/2022 - 13:18	Newsletter Test sent to:sly@lundbeck.com		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Anonymous

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter sent	Tue, 11/08/2022 - 13:18	Newsletter Test sent to:sly@lundbeck.com		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Anonymous

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER